Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 71 entries
Sorted by: Best Match Show Resources per page
Diagnosis and treatment of asymptomatic left ventricular systolic dysfunction after myocardial infarction.

ISRN cardiology

Ajello L, Coppola G, Corrado E, La Franca E, Rotolo A, Assennato P.
PMID: 23577268
ISRN Cardiol. 2013;2013:731285. doi: 10.1155/2013/731285. Epub 2013 Mar 12.

The increased survival after acute myocardial infarction induced an increase in heart failure with left ventricular systolic dysfunction. Early detection and treatment of asymptomatic left ventricular systolic dysfunction give the chance to improve outcomes and to reduce costs due...

Cite
Ajello L, Coppola G, Corrado E, et al. Diagnosis and treatment of asymptomatic left ventricular systolic dysfunction after myocardial infarction. ISRN Cardiol. 2013;2013:731285doi: 10.1155/2013/731285.
Ajello, L., Coppola, G., Corrado, E., La Franca, E., Rotolo, A., & Assennato, P. (2013). Diagnosis and treatment of asymptomatic left ventricular systolic dysfunction after myocardial infarction. ISRN cardiology, 2013731285. https://doi.org/10.1155/2013/731285
Ajello, Laura, et al. "Diagnosis and treatment of asymptomatic left ventricular systolic dysfunction after myocardial infarction." ISRN cardiology vol. 2013 (2013): 731285. doi: https://doi.org/10.1155/2013/731285
Ajello L, Coppola G, Corrado E, La Franca E, Rotolo A, Assennato P. Diagnosis and treatment of asymptomatic left ventricular systolic dysfunction after myocardial infarction. ISRN Cardiol. 2013;2013:731285. doi: 10.1155/2013/731285. Epub 2013 Mar 12. PMID: 23577268; PMCID: PMC3610361.
Copy Download .nbib Format: NLM
Left ventricular hypertrophy is associated with diastolic filling alterations in normotensive offspring of hypertensive nigerians.

ISRN cardiology

Kolo PM, Sanya EO, Omotoso AB, Soladoye A, Ogunmodede JA.
PMID: 23193485
ISRN Cardiol. 2012;2012:256738. doi: 10.5402/2012/256738. Epub 2012 Oct 30.

Contribution of left ventricular diastolic dysfunction to adverse events in patients with cardiovascular diseases is increasingly being recognized and individuals with pedigree for hypertension are thought to exhibit anatomic and or functional changes in their left ventricle before they...

Cite
Kolo PM, Sanya EO, Omotoso AB, et al. Left ventricular hypertrophy is associated with diastolic filling alterations in normotensive offspring of hypertensive nigerians. ISRN Cardiol. 2012;2012:256738doi: 10.5402/2012/256738.
Kolo, P. M., Sanya, E. O., Omotoso, A. B., Soladoye, A., & Ogunmodede, J. A. (2012). Left ventricular hypertrophy is associated with diastolic filling alterations in normotensive offspring of hypertensive nigerians. ISRN cardiology, 2012256738. https://doi.org/10.5402/2012/256738
Kolo, P M, et al. "Left ventricular hypertrophy is associated with diastolic filling alterations in normotensive offspring of hypertensive nigerians." ISRN cardiology vol. 2012 (2012): 256738. doi: https://doi.org/10.5402/2012/256738
Kolo PM, Sanya EO, Omotoso AB, Soladoye A, Ogunmodede JA. Left ventricular hypertrophy is associated with diastolic filling alterations in normotensive offspring of hypertensive nigerians. ISRN Cardiol. 2012;2012:256738. doi: 10.5402/2012/256738. Epub 2012 Oct 30. PMID: 23193485; PMCID: PMC3501814.
Copy Download .nbib Format: NLM
Risk factors for asymptomatic ventricular dysfunction in rheumatoid arthritis patients.

ISRN cardiology

Garza-García C, Rocío SS, Orea-Tejeda A, Castillo-Martínez L, Eduardo C, López-Campos JL, Keirns-Davis C.
PMID: 24368945
ISRN Cardiol. 2013 Dec 03;2013:635439. doi: 10.1155/2013/635439. eCollection 2013.

Objective. The aim of the study was to describe echocardiographic abnormalities in patients with rheumatoid arthritis, concurrent systemic comorbidities, rheumatologic clinical activity, serologic markers of rheumatoid arthritis, and inflammatory activity. Methods. In an observational, cross-sectional study, rheumatoid arthritis outpatients...

Cite
Garza-García C, Rocío SS, Orea-Tejeda A, et al. Risk factors for asymptomatic ventricular dysfunction in rheumatoid arthritis patients. ISRN Cardiol. 2013;2013:635439doi: 10.1155/2013/635439.
Garza-García, C., Rocío, S. S., Orea-Tejeda, A., Castillo-Martínez, L., Eduardo, C., López-Campos, J. L., & Keirns-Davis, C. (2013). Risk factors for asymptomatic ventricular dysfunction in rheumatoid arthritis patients. ISRN cardiology, 2013635439. https://doi.org/10.1155/2013/635439
Garza-García, Carlos, et al. "Risk factors for asymptomatic ventricular dysfunction in rheumatoid arthritis patients." ISRN cardiology vol. 2013 (2013): 635439. doi: https://doi.org/10.1155/2013/635439
Garza-García C, Rocío SS, Orea-Tejeda A, Castillo-Martínez L, Eduardo C, López-Campos JL, Keirns-Davis C. Risk factors for asymptomatic ventricular dysfunction in rheumatoid arthritis patients. ISRN Cardiol. 2013 Dec 03;2013:635439. doi: 10.1155/2013/635439. eCollection 2013. PMID: 24368945; PMCID: PMC3866864.
Copy Download .nbib Format: NLM
Hybrid surgical and catheter treatment for atrial fibrillation.

ISRN cardiology

Kaneko T, Aranki SF.
PMID: 24455303
ISRN Cardiol. 2013 Dec 16;2013:920635. doi: 10.1155/2013/920635. eCollection 2013 Dec 16.

Advances in surgery for atrial fibrillation from cut and sew technique to thoracoscopy and new energy source have enabled minimally invasive approach which avoids median sternotomy and cardiopulmonary bypass. However, minimally invasive approach is unable to match the outcome...

Cite
Kaneko T, Aranki SF. Hybrid surgical and catheter treatment for atrial fibrillation. ISRN Cardiol. 2013;2013:920635doi: 10.1155/2013/920635.
Kaneko, T., & Aranki, S. F. (2013). Hybrid surgical and catheter treatment for atrial fibrillation. ISRN cardiology, 2013920635. https://doi.org/10.1155/2013/920635
Kaneko, Tsuyoshi, and Aranki, Sary F. "Hybrid surgical and catheter treatment for atrial fibrillation." ISRN cardiology vol. 2013 (2013): 920635. doi: https://doi.org/10.1155/2013/920635
Kaneko T, Aranki SF. Hybrid surgical and catheter treatment for atrial fibrillation. ISRN Cardiol. 2013 Dec 16;2013:920635. doi: 10.1155/2013/920635. eCollection 2013 Dec 16. PMID: 24455303; PMCID: PMC3876832.
Copy Download .nbib Format: NLM
High-Bandpass Filters in Electrocardiography: Source of Error in the Interpretation of the ST Segment.

ISRN cardiology

Buendía-Fuentes F, Arnau-Vives MA, Arnau-Vives A, Jiménez-Jiménez Y, Rueda-Soriano J, Zorio-Grima E, Osa-Sáez A, Martínez-Dolz LV, Almenar-Bonet L, Palencia-Pérez MA.
PMID: 22778996
ISRN Cardiol. 2012;2012:706217. doi: 10.5402/2012/706217. Epub 2012 Jun 21.

Introduction. Artifactual variations in the ST segment may lead to confusion with acute coronary syndromes. Objective. To evaluate how the technical characteristics of the recording mode may distort the ST segment. Material and Method. We made a series of...

Cite
Buendía-Fuentes F, Arnau-Vives MA, Arnau-Vives A, et al. High-Bandpass Filters in Electrocardiography: Source of Error in the Interpretation of the ST Segment. ISRN Cardiol. 2012;2012:706217doi: 10.5402/2012/706217.
Buendía-Fuentes, F., Arnau-Vives, M. A., Arnau-Vives, A., Jiménez-Jiménez, Y., Rueda-Soriano, J., Zorio-Grima, E., Osa-Sáez, A., Martínez-Dolz, L. V., Almenar-Bonet, L., & Palencia-Pérez, M. A. (2012). High-Bandpass Filters in Electrocardiography: Source of Error in the Interpretation of the ST Segment. ISRN cardiology, 2012706217. https://doi.org/10.5402/2012/706217
Buendía-Fuentes, F, et al. "High-Bandpass Filters in Electrocardiography: Source of Error in the Interpretation of the ST Segment." ISRN cardiology vol. 2012 (2012): 706217. doi: https://doi.org/10.5402/2012/706217
Buendía-Fuentes F, Arnau-Vives MA, Arnau-Vives A, Jiménez-Jiménez Y, Rueda-Soriano J, Zorio-Grima E, Osa-Sáez A, Martínez-Dolz LV, Almenar-Bonet L, Palencia-Pérez MA. High-Bandpass Filters in Electrocardiography: Source of Error in the Interpretation of the ST Segment. ISRN Cardiol. 2012;2012:706217. doi: 10.5402/2012/706217. Epub 2012 Jun 21. PMID: 22778996; PMCID: PMC3388307.
Copy Download .nbib Format: NLM
Risks and Benefits of Thrombolytic, Antiplatelet, and Anticoagulant Therapies for ST Segment Elevation Myocardial Infarction: Systematic Review.

ISRN cardiology

Nascimento BR, de Sousa MR, Demarqui FN, Ribeiro AL.
PMID: 24653840
ISRN Cardiol. 2014 Feb 06;2014:416253. doi: 10.1155/2014/416253. eCollection 2014.

Objectives. Assess the impact of associating thrombolytics, anticoagulants, antiplatelets, and primary angioplasty (PA) on death, reinfarction (AMI), and major bleeding (MB) in STEMI therapy. Methods. Medline search was performed to identify randomized trials comparing these classes in STEMI treatment,...

Cite
Nascimento BR, de Sousa MR, Demarqui FN, et al. Risks and Benefits of Thrombolytic, Antiplatelet, and Anticoagulant Therapies for ST Segment Elevation Myocardial Infarction: Systematic Review. ISRN Cardiol. 2014;2014:416253doi: 10.1155/2014/416253.
Nascimento, B. R., de Sousa, M. R., Demarqui, F. N., & Ribeiro, A. L. (2014). Risks and Benefits of Thrombolytic, Antiplatelet, and Anticoagulant Therapies for ST Segment Elevation Myocardial Infarction: Systematic Review. ISRN cardiology, 2014416253. https://doi.org/10.1155/2014/416253
Nascimento, Bruno Ramos, et al. "Risks and Benefits of Thrombolytic, Antiplatelet, and Anticoagulant Therapies for ST Segment Elevation Myocardial Infarction: Systematic Review." ISRN cardiology vol. 2014 (2014): 416253. doi: https://doi.org/10.1155/2014/416253
Nascimento BR, de Sousa MR, Demarqui FN, Ribeiro AL. Risks and Benefits of Thrombolytic, Antiplatelet, and Anticoagulant Therapies for ST Segment Elevation Myocardial Infarction: Systematic Review. ISRN Cardiol. 2014 Feb 06;2014:416253. doi: 10.1155/2014/416253. eCollection 2014. PMID: 24653840; PMCID: PMC3933035.
Copy Download .nbib Format: NLM
Angiotensin receptor antagonists to prevent sudden death in heart failure: does the dose matter?.

ISRN cardiology

Francia P, Palano F, Tocci G, Adduci C, Ricotta A, Semprini L, Caprinozzi M, Balla C, Volpe M.
PMID: 24653841
ISRN Cardiol. 2014 Feb 06;2014:652421. doi: 10.1155/2014/652421. eCollection 2014.

International guidelines recommend ICD implantation in patients with severe left ventricular dysfunction of any origin only after careful optimization of medical therapy. Indeed, major randomized clinical trials suggest that suboptimal use of fundamental drugs, such as ACE inhibitors (ACE-i)...

Cite
Francia P, Palano F, Tocci G, et al. Angiotensin receptor antagonists to prevent sudden death in heart failure: does the dose matter?. ISRN Cardiol. 2014;2014:652421doi: 10.1155/2014/652421.
Francia, P., Palano, F., Tocci, G., Adduci, C., Ricotta, A., Semprini, L., Caprinozzi, M., Balla, C., & Volpe, M. (2014). Angiotensin receptor antagonists to prevent sudden death in heart failure: does the dose matter?. ISRN cardiology, 2014652421. https://doi.org/10.1155/2014/652421
Francia, Pietro, et al. "Angiotensin receptor antagonists to prevent sudden death in heart failure: does the dose matter?." ISRN cardiology vol. 2014 (2014): 652421. doi: https://doi.org/10.1155/2014/652421
Francia P, Palano F, Tocci G, Adduci C, Ricotta A, Semprini L, Caprinozzi M, Balla C, Volpe M. Angiotensin receptor antagonists to prevent sudden death in heart failure: does the dose matter?. ISRN Cardiol. 2014 Feb 06;2014:652421. doi: 10.1155/2014/652421. eCollection 2014. PMID: 24653841; PMCID: PMC3933036.
Copy Download .nbib Format: NLM
Doxorubicin and NRG-1/erbB4-Deficiency Affect Gene Expression Profile: Involving Protein Homeostasis in Mouse.

ISRN cardiology

Vasti C, Witt H, Said M, Sorroche P, García-Rivello H, Ruiz-Noppinger P, Hertig CM.
PMID: 22970387
ISRN Cardiol. 2012;2012:745185. doi: 10.5402/2012/745185. Epub 2012 Aug 29.

The accumulating evidence demonstrates the essential role of neuregulin-1 signaling in the adult heart, and, moreover, indicates that an impaired neuregulin signaling exacerbates the doxorubicin-mediated cardiac toxicity. Despite this strong data, the specific cardiomyocyte targets of the active erbB2/erbB4...

Cite
Vasti C, Witt H, Said M, et al. Doxorubicin and NRG-1/erbB4-Deficiency Affect Gene Expression Profile: Involving Protein Homeostasis in Mouse. ISRN Cardiol. 2012;2012:745185doi: 10.5402/2012/745185.
Vasti, C., Witt, H., Said, M., Sorroche, P., García-Rivello, H., Ruiz-Noppinger, P., & Hertig, C. M. (2012). Doxorubicin and NRG-1/erbB4-Deficiency Affect Gene Expression Profile: Involving Protein Homeostasis in Mouse. ISRN cardiology, 2012745185. https://doi.org/10.5402/2012/745185
Vasti, Cecilia, et al. "Doxorubicin and NRG-1/erbB4-Deficiency Affect Gene Expression Profile: Involving Protein Homeostasis in Mouse." ISRN cardiology vol. 2012 (2012): 745185. doi: https://doi.org/10.5402/2012/745185
Vasti C, Witt H, Said M, Sorroche P, García-Rivello H, Ruiz-Noppinger P, Hertig CM. Doxorubicin and NRG-1/erbB4-Deficiency Affect Gene Expression Profile: Involving Protein Homeostasis in Mouse. ISRN Cardiol. 2012;2012:745185. doi: 10.5402/2012/745185. Epub 2012 Aug 29. PMID: 22970387; PMCID: PMC3437290.
Copy Download .nbib Format: NLM
A method for ventricular late potentials detection using time-frequency representation and wavelet denoising.

ISRN cardiology

Gadaleta M, Giorgio A.
PMID: 22957271
ISRN Cardiol. 2012;2012:258769. doi: 10.5402/2012/258769. Epub 2012 Aug 26.

This study proposes a method for ventricular late potentials (VLPs) detection using time-frequency representation and wavelet denoising in high-resolution electrocardiography (HRECG). The analysis is performed both with the signal averaged electrocardiography (SAECG) and in real time. A comparison between...

Cite
Gadaleta M, Giorgio A. A method for ventricular late potentials detection using time-frequency representation and wavelet denoising. ISRN Cardiol. 2012;2012:258769doi: 10.5402/2012/258769.
Gadaleta, M., & Giorgio, A. (2012). A method for ventricular late potentials detection using time-frequency representation and wavelet denoising. ISRN cardiology, 2012258769. https://doi.org/10.5402/2012/258769
Gadaleta, Matteo, and Giorgio, Agostino. "A method for ventricular late potentials detection using time-frequency representation and wavelet denoising." ISRN cardiology vol. 2012 (2012): 258769. doi: https://doi.org/10.5402/2012/258769
Gadaleta M, Giorgio A. A method for ventricular late potentials detection using time-frequency representation and wavelet denoising. ISRN Cardiol. 2012;2012:258769. doi: 10.5402/2012/258769. Epub 2012 Aug 26. PMID: 22957271; PMCID: PMC3432549.
Copy Download .nbib Format: NLM
Association of oral health and cardiovascular disease risk factors "results from a community based study on 5900 adult subjects".

ISRN cardiology

Najafipour H, Malek Mohammadi T, Rahim F, Haghdoost AA, Shadkam M, Afshari M.
PMID: 23956878
ISRN Cardiol. 2013 Jul 09;2013:782126. doi: 10.1155/2013/782126. eCollection 2013.

Objectives. This study aimed to determine the association between some oral health status as a risk factor for cardiac diseases and other cardiovascular disease (CVD) risk factors in a sample of Iranian population in 2011. Methods. The study recruited...

Cite
Najafipour H, Malek Mohammadi T, Rahim F, et al. Association of oral health and cardiovascular disease risk factors "results from a community based study on 5900 adult subjects". ISRN Cardiol. 2013;2013:782126doi: 10.1155/2013/782126.
Najafipour, H., Malek Mohammadi, T., Rahim, F., Haghdoost, A. A., Shadkam, M., & Afshari, M. (2013). Association of oral health and cardiovascular disease risk factors "results from a community based study on 5900 adult subjects". ISRN cardiology, 2013782126. https://doi.org/10.1155/2013/782126
Najafipour, Hamid, et al. "Association of oral health and cardiovascular disease risk factors "results from a community based study on 5900 adult subjects"." ISRN cardiology vol. 2013 (2013): 782126. doi: https://doi.org/10.1155/2013/782126
Najafipour H, Malek Mohammadi T, Rahim F, Haghdoost AA, Shadkam M, Afshari M. Association of oral health and cardiovascular disease risk factors "results from a community based study on 5900 adult subjects". ISRN Cardiol. 2013 Jul 09;2013:782126. doi: 10.1155/2013/782126. eCollection 2013. PMID: 23956878; PMCID: PMC3727197.
Copy Download .nbib Format: NLM
The intrinsic autonomic nervous system in atrial fibrillation: a review.

ISRN cardiology

He B, Scherlag BJ, Nakagawa H, Lazzara R, Po SS.
PMID: 22778995
ISRN Cardiol. 2012;2012:490674. doi: 10.5402/2012/490674. Epub 2012 Jun 19.

The procedure of catheter ablation for the treatment of drug resistant atrial fibrillation (AF) has evolved but still relies on lesion sets intended to isolate areas of focal firing, mainly the myocardial sleeves of the pulmonary veins (PVs), from...

Cite
He B, Scherlag BJ, Nakagawa H, et al. The intrinsic autonomic nervous system in atrial fibrillation: a review. ISRN Cardiol. 2012;2012:490674doi: 10.5402/2012/490674.
He, B., Scherlag, B. J., Nakagawa, H., Lazzara, R., & Po, S. S. (2012). The intrinsic autonomic nervous system in atrial fibrillation: a review. ISRN cardiology, 2012490674. https://doi.org/10.5402/2012/490674
He, Bo, et al. "The intrinsic autonomic nervous system in atrial fibrillation: a review." ISRN cardiology vol. 2012 (2012): 490674. doi: https://doi.org/10.5402/2012/490674
He B, Scherlag BJ, Nakagawa H, Lazzara R, Po SS. The intrinsic autonomic nervous system in atrial fibrillation: a review. ISRN Cardiol. 2012;2012:490674. doi: 10.5402/2012/490674. Epub 2012 Jun 19. PMID: 22778995; PMCID: PMC3385664.
Copy Download .nbib Format: NLM
Human immunodeficiency virus and pulmonary arterial hypertension.

ISRN cardiology

Mirrakhimov AE, Ali AM, Barbaryan A, Prueksaritanond S.
PMID: 24027641
ISRN Cardiol. 2013 Aug 21;2013:903454. doi: 10.1155/2013/903454.

Human immunodeficiency virus- (HIV-) related pulmonary arterial hypertension (PAH) is a rare complication of HIV infection. The pathophysiology of HIV-related PAH is complex, with viral proteins seeming to play the major role. However, other factors, such as coinfection with...

Cite
Mirrakhimov AE, Ali AM, Barbaryan A, et al. Human immunodeficiency virus and pulmonary arterial hypertension. ISRN Cardiol. 2013;2013:903454doi: 10.1155/2013/903454.
Mirrakhimov, A. E., Ali, A. M., Barbaryan, A., & Prueksaritanond, S. (2013). Human immunodeficiency virus and pulmonary arterial hypertension. ISRN cardiology, 2013903454. https://doi.org/10.1155/2013/903454
Mirrakhimov, Aibek E, et al. "Human immunodeficiency virus and pulmonary arterial hypertension." ISRN cardiology vol. 2013 (2013): 903454. doi: https://doi.org/10.1155/2013/903454
Mirrakhimov AE, Ali AM, Barbaryan A, Prueksaritanond S. Human immunodeficiency virus and pulmonary arterial hypertension. ISRN Cardiol. 2013 Aug 21;2013:903454. doi: 10.1155/2013/903454. PMID: 24027641; PMCID: PMC3763567.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 71 entries